The Effectiveness of a Behavioral Program on Severity of Urinary Incontinence Among Iranian Women With Multiple Sclerosis

Document Type: Original Article

Authors

1 Educational Management, Tehran Medical Sciences Branch Islamic Azad University, Tehran, Iran

2 Department of Nursing, Faculty of Nursing and Midwifery, Qazvin University of Medical Sciences, Qazvin, Iran

Abstract

 
Background and aims: Urinary incontinence is common among multiple sclerosis (MS) patients, which affects their quality of life negatively. This study examined the effectiveness of a behavioral training program on severity of urinary incontinence among Iranian women with MS.
Methods: This is a quasi experimental study. The sample was selected using purposeful sampling from all those who presented for routine follow-up care and treatment in an MS clinic in Tehran from March 2015 to September 2015. The training consisted of 2 sessions (each were 45 minutes) video, small group discussion and group lecture in which all aspects of the urinary incontinence were taught. Before the study initiation, patients were asked to complete the Incontinence Questionnaire-Urinary Incontinence Short Form (ICIQUI-SF) and a demographic questionnaire. Three month after the first educational intervention, MS patients were reassessed using the ICIQUI-SF. Data analyzed in SPSS 21.
Results: The mean total scores of ICIQ-SF were 12.4 ± 3.3 and 7.1 ± 3.2 before and after training, respectively. According to the results of paired t test, this difference before and after study was statistically significant (P < 0.001). The mean scores of "number of urine leak" were 2.7 ± 0.9 and 1.5 ± 0.8 before and after intervention, respectively (P < 0.001). The mean scores of "amount of urine leak" were 3.3 ± 1.4 and 2.1 ± 0.9 before and after intervention, respectively (P < 0.001). The mean scores of "effect of urine leak on everyday life" were 6.3 ± 2.1 and 3.6 ± 2.0 before and after intervention, respectively (P < 0.001).
Conclusion: Behavioral training could be effective strategy in management of bladder dysfunction in MS patients. Health-care providers should be aware of this and plan for use. Further study in this regard is strongly recommended.

Keywords


 

1. Massot C, Khenioui H, Agnani O, Guyot MA, Hautecoeur P, Donze C. Stress urinary incontinence in women with multiple sclerosis. Int Neurourol J. 2016;20(3):224-31. doi: 10.5213/ inj.1630490.245.

2. Shah P. Symptomatic management in multiple sclerosis. Ann Indian Acad Neurol. 2015;18(Suppl 1):S35-42. doi: 10.4103/0972-2327.164827.

3. Buhse M. Assessment of caregiver burden in families of persons with multiple sclerosis. J Neurosci Nurs. 2008;40(1):25-31.

4. Masoudi R, Abedi H, Abedi P, Mohammadianinejad SE. Experiences of Iranian multiple sclerosis patients’ and their caregivers’ regarding care and treatment outcomes. Jundishapur J Chronic Dis Care. 2014;3(1):21-31.

5. Uccelli MM. The impact of multiple sclerosis on family members: a review of the literature. Neurodegener Dis Manag. 2014;4(2):177-85. doi: 10.2217/nmt.14.6.

6. Rintala A, Hakkinen A, Paltamaa J. Ten-year follow-up of health-related quality of life among ambulatory persons with multiple sclerosis at baseline. Qual Life Res. 2016;25(12):3119-27. doi: 10.1007/s11136-016-1347-x.

7. Leibach GG, Stern M, Arelis AA, Islas MA, Barajas BV. Mental Health and Health-Related Quality of Life in Multiple Sclerosis Caregivers in Mexico. Int J MS Care. 2016;18(1):19-26. doi: 10.7224/1537-2073.2014-094.

8. Wingerchuk DM. Environmental factors in multiple sclerosis: Epstein-Barr virus, vitamin D, and cigarette smoking. Mt Sinai J Med. 2011;78(2):221-30. doi: 10.1002/msj.20240.

9. Ascherio A. Environmental factors in multiple sclerosis. Expert Rev Neurother. 2013;13(12 Suppl):3-9. doi: 10.1586/14737175.2013.865866.

10. Disanto G, Morahan JM, Ramagopalan SV. Multiple sclerosis: risk factors and their interactions. CNS Neurol Disord Drug Targets. 2012;11(5):545-55.

11. Evans C, Beland SG, Kulaga S, Wolfson C, Kingwell E, Marriott J, et al. Incidence and prevalence of multiple sclerosis in the Americas: a systematic review. Neuroepidemiology. 2013;40(3):195-210. doi: 10.1159/000342779.

12. Browne P, Chandraratna D, Angood C, Tremlett H, Baker C, Taylor BV, et al. Atlas of Multiple Sclerosis 2013: A growing global problem with widespread inequity. Neurology. 2014;83(11):1022-4. doi: 10.1212/wnl.0000000000000768.

13. Nasr Z, Majed M, Rostami A, Sahraian MA, Minagar A, Amini A, et al. Prevalence of multiple sclerosis in Iranian emigrants: review of the evidence. Neurol Sci. 2016;37(11):1759-63. doi: 10.1007/s10072-016-2641-7.

14. Ben-Zacharia AB. Therapeutics for multiple sclerosis symptoms. Mt Sinai J Med. 2011;78(2):176-91. doi: 10.1002/ msj.20245.

15. Schapiro RT. The symptomatic management of multiple sclerosis. Ann Indian Acad Neurol. 2009;12(4):291-5. doi: 10.4103/0972-2327.58278.

16. Cameron MH, Wagner JM. Gait abnormalities in multiple sclerosis: pathogenesis, evaluation, and advances in treatment. Curr Neurol Neurosci Rep. 2011;11(5):507-15. doi: 10.1007/ s11910-011-0214-y.

17. Chalah MA, Ayache SS. Psychiatric event in multiple sclerosis: could it be the tip of the iceberg? Rev Bras Psiquiatr. 2017. doi: 10.1590/1516-4446-2016-2105.

18. Nourbakhsh B, Azevedo C, Nunan-Saah J, Maghzi AH, Spain R, Pelletier D, et al. Longitudinal associations between brain structural changes and fatigue in early MS. Mult Scler Relat Disord. 2016;5:29-33. doi: 10.1016/j.msard.2015.10.006.

19. Sadiq A, Brucker BM. Management of neurogenic lower urinary tract dysfunction in multiple sclerosis patients. Curr Urol Rep. 2015;16(7):44. doi: 10.1007/s11934-015-0519-5.

20. Khalaf KM, Coyne KS, Globe DR, Armstrong EP, Malone DC, Burks J. Lower urinary tract symptom prevalence and management among patients with multiple sclerosis. Int J MS Care. 2015;17(1):14-25. doi: 10.7224/1537-2073.2013-040.

21. Rafii F, Shareinia H, Seyedalshohahadaee M, Sarraf P, Mahmoodi F. The effect of Pelvic Floor Muscle Exercise Training on Urinary Incontinence in Patients with Multiple Sclerosis. Iran J Nurs. 2014;27(87):43-54.

22. Hajebrahimi S, Nourizadeh D, Hamedani R, Pezeshki MZ. Validity and reliability of the International Consultation on Incontinence Questionnaire-Urinary Incontinence Short

 

Form and its correlation with urodynamic findings. Urol J. 2012;9(4):685-90.

23. Dehghani A, Mohammadkhan Kermanshahi S, Memarian R. Evaluation of the Needs of Patients with Multiple Sclerosis. Zahedan Journal of Research in Medical Sciences. 2012;14(9):104-6.

24. Burks JS, Bigley GK, Hill HH. Rehabilitation challenges in multiple sclerosis. Ann Indian Acad Neurol. 2009;12(4):296- 306. doi: 10.4103/0972-2327.58273.

25. Rabiei L, Abedi H, Abedi P, Zarea K, Masoudi R. Perspectives and Experiences Related to Help-Seeking Behaviors: A Content Analysis Study of Iranian Patients With Multiple Sclerosis. J Nurs Res. 2017. doi: 10.1097/jnr.0000000000000216.

26. Sand PK, Sand RI. The diagnosis and management of lower urinary tract symptoms in multiple sclerosis patients. Dis Mon. 2013;59(7):261-8. doi: 10.1016/j.disamonth.2013.03.013.

27. Rafii F, Sajjadi M, Shareinia H , Sarraf P, Seyedalshohahadaee M. Pelvic floor muscle training instruction to control urinary incontinence and its resulting stress, anxiety and depression in patients with Multiple Sclerosis. Jundishapur J Chronic Dis Care. 2017;6(1):e37333. doi: 10.17795/jjcdc-37333.

28. Lucio AC, Perissinoto MC, Natalin RA, Prudente A, Damasceno BP, D’Ancona C A. A comparative study of pelvic floor muscle training in women with multiple sclerosis: its impact on lower urinary tract symptoms and quality of life. Clinics (Sao Paulo). 2011;66(9):1563-8.